Several studies have reported that a lower serum ALB value was linked to a shorter DFS and OS in a variety of cancers, however, only a few studies have focused on the clinical impact on the level of serum albumin in head and neck cancer patients (13, 18–20). The gene discussed is ALB; the disease is head and neck cancer.